PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study

The treatment of diseases that affect the central nervous system (CNS) represents a great research challenge due to the restriction imposed by the blood–brain barrier (BBB) to allow the passage of drugs into the brain. However, the use of modified nanomedicines engineered with different ligands that...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmaceutics
Egile Nagusiak: Hoyos-Ceballos, Gina P., Ruozi, Barbara, Ottonelli, Ilaria, Da Ros, Federica, Vandelli, Maria Angela, Forni, Flavio, Daini, Eleonora, Vilella, Antonietta, Zoli, Michele, Tosi, Giovanni, Duskey, Jason T., López-Osorio, Betty L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7023215/
https://ncbi.nlm.nih.gov/pubmed/31963430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12010072
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak